A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
08/2011
08/25/2011	WO2011103196A1 Aryl carboxamide derivatives as sodium channel inhibitors for treatment of pain
08/25/2011	WO2011103177A1 Nucleoside-containing compositions and methods for treating red blood cells
08/25/2011	WO2011103175A2 Oxysterols that activate liver x receptor signaling and inhibit hedgehog signaling
08/25/2011	WO2011103156A1 Glycine chroman-6-sulfonamides for use as inhibitors of diacylglycerol lipase
08/25/2011	WO2011103150A2 Lyophilized preparations of bendamustine
08/25/2011	WO2011103134A1 Aminothiazolones as estrogen related receptor-alpha modulators
08/25/2011	WO2011103130A1 Aminothiazolones as estrogen related receptor-alpha modulators
08/25/2011	WO2011103128A1 Treatment of metabolic syndrome with novel amines
08/25/2011	WO2011103127A1 Treatment of metabolic syndrome with piperidine amides
08/25/2011	WO2011103126A1 Treatment of metabolic syndrome with piperidine amides
08/25/2011	WO2011103123A2 Reducing short-chain fatty acids and energy uptake in obese humans by managing their intestinal microbial communities
08/25/2011	WO2011103111A1 Method of treating disease involving myelin and/or axonal loss
08/25/2011	WO2011103091A1 Phenyl-heteroaryl derivatives and methods of use thereof
08/25/2011	WO2011103089A1 Crystalline forms of sodium 4-{[9-chloro-7-(2-fluoro-6--methoxyphenyl)-5h -pyrimido[5,4-d][2]benzazepin-2yl]amino}-2-methoxybenzoate
08/25/2011	WO2011103063A1 Therapeutic compounds
08/25/2011	WO2011103055A1 Glycine sulfonamides for use as inhibitors of diacylglycerol lipase
08/25/2011	WO2011103028A2 Compositions and methods for inhibiting mmset
08/25/2011	WO2011103018A1 Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereof
08/25/2011	WO2011103016A2 Compositions and methods for inhibiting ezh2
08/25/2011	WO2011103007A2 10'-fluorinated vinca alkaloids provide enhanced biological activity against mdr cancer cells
08/25/2011	WO2011102964A1 Heterocycles as potassium channel modulators
08/25/2011	WO2011102901A1 Prevention and treatment of alzheimer's disease by amyloid beta peptide and sphingosine-1-phosphate
08/25/2011	WO2011102795A1 New crystalline form of a cyclopropyl benzamide derivative
08/25/2011	WO2011102793A1 Solid forms comprising a cyclopropyl amide derivative
08/25/2011	WO2011102788A1 Oral smokeless tobacco products and oral smokeless non-tobacco snuff products comprising carbamide or carbamide salts.
08/25/2011	WO2011102695A2 Composition for preventing or treating diseases caused by over-expression of lxrα, containing liquiritigenin or isoliquiritigenin as active ingredient
08/25/2011	WO2011102668A2 Colchicine derivatives or pharmaceutically acceptable salts thereof, method for preparing said derivatives, and pharmaceutical composition comprising said derivatives
08/25/2011	WO2011102660A2 A novel 5-membered heterocycle derivatives and manufacturing process thereof
08/25/2011	WO2011102657A2 Composition for percutaneous administration of tolterodine with improved skin permeation
08/25/2011	WO2011102655A2 Composition for percutaneous administration of tolterodine with reduced skin irritation
08/25/2011	WO2011102577A1 Novel use for scopolin and derivatives thereof
08/25/2011	WO2011102529A1 Epithelial cell-cell adhesion enhancer, and ameliorating, therapeutic or prophylactic agent for allergic diseases using same
08/25/2011	WO2011102514A1 Aromatic ring compound
08/25/2011	WO2011102506A1 Sustained-release solid preparation for oral use
08/25/2011	WO2011102505A1 Sustained-release solid preparation for oral use
08/25/2011	WO2011102504A1 Sustained-release solid preparation for oral use
08/25/2011	WO2011102460A1 Prophylactic or therapeutic agent for gastric ulcer, medicinal agent for oral administration, and process for production of prophylactic or therapeutic agent for gastric ulcer
08/25/2011	WO2011102436A1 Tgf-β signal transduction inhibitor
08/25/2011	WO2011102414A1 Oligonucleotide derivative
08/25/2011	WO2011102404A1 Imidazole derivative
08/25/2011	WO2011102399A1 Heterocyclic compound
08/25/2011	WO2011102243A1 Neuropathic pain alleviating agent
08/25/2011	WO2011102149A1 Use of ep4 receptor antagonists in the treatment of il-23 mediated diseases
08/25/2011	WO2011101869A1 Adeno-associated virus 2/8 - micro rna-101 therapy for liver cancer
08/25/2011	WO2011101862A1 Stabilized fluconazole polymorph iii formulation
08/25/2011	WO2011101860A1 Nicotine-containing soft gelatin pastilles
08/25/2011	WO2011101859A1 A novel water soluble curcumin loaded nanoparticulate system for cancer therapy
08/25/2011	WO2011101830A1 A medicinal fusidic acid cream made using sodium fusidate and incorporating a biopolymer and clobetasone, and a process to make it
08/25/2011	WO2011101828A1 A medicinal fusidic acid cream made using sidium fusidate and incorporating a biopolymer and betamethasone, and a process to make it
08/25/2011	WO2011101826A1 A medicinal fusidic acid cream made using sodium fusidate and incorporating a biopolymer, terbinafine and dexamethasone, and a process to make it
08/25/2011	WO2011101825A1 A medicinal fusidic acid cream made using sodium fusidate and incorporating a biopolymer, clotrimazole and clobetasone, and a process to make it
08/25/2011	WO2011101824A1 A medicinal fusidic acid cream made using sodium fusidate and incorporating a biopolymer, miconazole, dexamethasone, and a process to make it
08/25/2011	WO2011101823A1 A medicinal fusidic acid cream made using sodium fusidate and incorporating biopolymer, clotrimazole and dexamethasone, and a process to make it
08/25/2011	WO2011101816A1 An improved process for the preparation of amorphous atorvastatin calcium
08/25/2011	WO2011101806A1 Bicyclic compounds and their uses as dual c-src / jak inhibitors
08/25/2011	WO2011101805A1 Pyrazolo piperidine derivatives as nadph oxidase inhibitors
08/25/2011	WO2011101804A1 Pyrazolo piperidine derivatives as nadph oxidase inhibitors
08/25/2011	WO2011101802A1 Citicoline for the treatment of glaucoma and ocular hypertension
08/25/2011	WO2011101799A1 Pharmaceutical compositions for use in therapies for psychiatric disorders
08/25/2011	WO2011101787A1 Non peptidic 14-3-3 inhibitors and the use thereof
08/25/2011	WO2011101774A1 (r)-4-((4-((4-(tetrahydrofuran-3-yloxy)benzo[d]isoxazol-3-yloxy)methyl)piperidin-1-yl)methyl)tetrahydro-2h-pyran-4-ol, a partial agonist of 5-ht4 receptors
08/25/2011	WO2011101740A1 Improved processes for preparing ticagrelor intermediate, 4,6-dichloro-5-nitro-2-(propylthio)pyrimidine
08/25/2011	WO2011101710A1 Efflux pump inhibitors
08/25/2011	WO2011101677A1 Compounds for the treatment of renal cell carcinoma
08/25/2011	WO2011101644A1 Triazolo [4, 5 - b] pyridin derivatives
08/25/2011	WO2011101643A1 Compositions comprising perfluorooctanoic acid
08/25/2011	WO2011101631A1 Antimicrobial agent
08/25/2011	WO2011101602A1 Nanoemulsion for the delivery of at least two agents of interest
08/25/2011	WO2011101600A1 Use of a neutralising composition by ingestion to treat or prevent the appearance of aphthas
08/25/2011	WO2011101594A1 Use of synthetic polysulphated oligosaccharides as cleaning agents for a wound
08/25/2011	WO2011101558A1 Novel method for synthesizing ivabradine and the pharmaceutically acceptable acid addition salts thereof
08/25/2011	WO2011101456A2 Stabilized phenylcarbamate derivative in solid state
08/25/2011	WO2011101429A1 Pyrido[3,2-d]pyrimidine pi3k delta inhibitor compounds and methods of use
08/25/2011	WO2011101424A1 Tricyclic pyridine derivatives, medicaments containing such compounds, their use and process for their preparation
08/25/2011	WO2011101417A1 Deuterated pyrrolopyrimidine compounds as inhibitors of cdk4/6
08/25/2011	WO2011101409A1 Pyrrolopyrimidine compounds as inhibitors of cdk4/6
08/25/2011	WO2011101408A1 Method for preventing cancer metastasis
08/25/2011	WO2011101374A1 Compositions comprising amphetamin and lisdexamfetamine
08/25/2011	WO2011101367A1 Product for removing sea lice
08/25/2011	WO2011101304A2 Piperidine derivatives
08/25/2011	WO2011101297A1 Substituted spiroindolinones
08/25/2011	WO2011101239A2 Cosmetic or dermatological uses of a powder comprising a filler, an essential oil and a hydroxylated ester of polyol and of c4 to c16 carboxylic acid(s)
08/25/2011	WO2011101171A1 Nutritional composition
08/25/2011	WO2011101161A1 Pyrazole derivatives as jak inhibitors
08/25/2011	WO2011101114A2 An inhalable pharmaceutical composition
08/25/2011	WO2011101113A1 Pharmaceutical comprising myramistin
08/25/2011	WO2011100994A1 Pharmaceutical comprising myramistin
08/25/2011	WO2011100980A1 A method for preparation of the tetrasaccharide lacto-n-neotetraose (lnnt) containing n-acetyllactosamine
08/25/2011	WO2011100979A1 Production of 6'-o-sialyllactose and intermediates
08/25/2011	WO2011100840A1 Substituted 2-imidazolidones and analogs
08/25/2011	WO2011100838A1 Derivatives of 1-phenyl-1,5-dihydro-benzo[b] [1.4]diazepine-2.4-dione as inhibitors of hiv replication
08/25/2011	WO2011100805A1 Anti-viral formulations
08/25/2011	WO2011080593A3 Materials and methods for prevention and treatment of viral infections
08/25/2011	WO2011080589A3 Solid state forms of rasagiline salts
08/25/2011	WO2011080568A3 Novel pyrimidine compounds as mtor and p13k inhibitors
08/25/2011	WO2011080269A3 Pharmaceutical preparations comprising a cos releasing compound
08/25/2011	WO2011076946A3 Methods and compositions for the treatment of alzheimer
08/25/2011	WO2011075004A9 Anti-thrombosis aptamers and method for stabilizing the structure thereof
08/25/2011	WO2011066263A8 Transcription factor inhibitors and related compositions, formulations and methods
08/25/2011	WO2011060066A9 Methods of treating or preventing stent thrombosis

1 ... 1589 1590 1591 1592 1593 1594 1595 1596 1597 1598 1599 1600 1601 1602 1603 1604 1605 1606 1607 1608 1609 ... 7860